These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A review of induced pluripotent stem cell, direct conversion by trans-differentiation, direct reprogramming and oligodendrocyte differentiation. Prasad A; Manivannan J; Loong DT; Chua SM; Gharibani PM; All AH Regen Med; 2016 Mar; 11(2):181-91. PubMed ID: 26857809 [TBL] [Abstract][Full Text] [Related]
4. Dedifferentiation, transdifferentiation and cell fusion: in vivo reprogramming strategies for regenerative medicine. Pesaresi M; Sebastian-Perez R; Cosma MP FEBS J; 2019 Mar; 286(6):1074-1093. PubMed ID: 30103260 [TBL] [Abstract][Full Text] [Related]
5. Progress in the reprogramming of somatic cells. Ma T; Xie M; Laurent T; Ding S Circ Res; 2013 Feb; 112(3):562-74. PubMed ID: 23371904 [TBL] [Abstract][Full Text] [Related]
6. Engineering cell fate: Spotlight on cell-activation and signaling-directed lineage conversion. Ebrahimi B Tissue Cell; 2016 Oct; 48(5):475-87. PubMed ID: 27514850 [TBL] [Abstract][Full Text] [Related]
7. Transcription factor-mediated reprogramming: epigenetics and therapeutic potential. Firas J; Liu X; Lim SM; Polo JM Immunol Cell Biol; 2015 Mar; 93(3):284-9. PubMed ID: 25643615 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine. Xie M; Tang S; Li K; Ding S Acc Chem Res; 2017 May; 50(5):1202-1211. PubMed ID: 28453285 [TBL] [Abstract][Full Text] [Related]
10. Direct cell reprogramming: approaches, mechanisms and progress. Wang H; Yang Y; Liu J; Qian L Nat Rev Mol Cell Biol; 2021 Jun; 22(6):410-424. PubMed ID: 33619373 [TBL] [Abstract][Full Text] [Related]
11. Somatic cell reprogramming as a tool for neurodegenerative diseases. Ebrahimi A; Keske E; Mehdipour A; Ebrahimi-Kalan A; Ghorbani M Biomed Pharmacother; 2019 Apr; 112():108663. PubMed ID: 30970509 [TBL] [Abstract][Full Text] [Related]
12. Reprogramming and transdifferentiation shift the landscape of regenerative medicine. Guo J; Wang H; Hu X DNA Cell Biol; 2013 Oct; 32(10):565-72. PubMed ID: 23930590 [TBL] [Abstract][Full Text] [Related]
13. Neuronal Reprogramming for Tissue Repair and Neuroregeneration. Liou RH; Edwards TL; Martin KR; Wong RC Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560072 [TBL] [Abstract][Full Text] [Related]
14. Direct Reprogramming of Resident Non-Myocyte Cells and Its Potential for In Vivo Cardiac Regeneration. Perveen S; Vanni R; Lo Iacono M; Rastaldo R; Giachino C Cells; 2023 Apr; 12(8):. PubMed ID: 37190075 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic Control of Reprogramming and Transdifferentiation by Histone Modifications. Qin H; Zhao A; Zhang C; Fu X Stem Cell Rev Rep; 2016 Dec; 12(6):708-720. PubMed ID: 27623868 [TBL] [Abstract][Full Text] [Related]
16. Chemical transdifferentiation: closer to regenerative medicine. Xu A; Cheng L Front Med; 2016 Jun; 10(2):152-65. PubMed ID: 27142989 [TBL] [Abstract][Full Text] [Related]
17. Direct Reprogramming, Epigenetics, and Cardiac Regeneration. Kurotsu S; Suzuki T; Ieda M J Card Fail; 2017 Jul; 23(7):552-557. PubMed ID: 28529134 [TBL] [Abstract][Full Text] [Related]
18. Direct cell reprogramming for tissue engineering and regenerative medicine. Grath A; Dai G J Biol Eng; 2019; 13():14. PubMed ID: 30805026 [TBL] [Abstract][Full Text] [Related]
19. Effect of small molecules on cell reprogramming. Baranek M; Belter A; Naskręt-Barciszewska MZ; Stobiecki M; Markiewicz WT; Barciszewski J Mol Biosyst; 2017 Jan; 13(2):277-313. PubMed ID: 27918060 [TBL] [Abstract][Full Text] [Related]
20. Direct cellular reprogramming in Caenorhabditis elegans: facts, models, and promises for regenerative medicine. Zuryn S; Daniele T; Jarriault S Wiley Interdiscip Rev Dev Biol; 2012; 1(1):138-52. PubMed ID: 23801672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]